Page 36 - IMCJ19s1
P. 36

REVIEW OF EMERGING RESEARCH


            The Functional Medicine Approach to COVID-19:

            Virus-Specific Nutraceutical and Botanical Agents
            Evans JM , Luby R , Lukaczer D , Rountree R , Stone PM , Guilliams TG , Yanuck S , Messier H ,
                     1
                                                      3
                                                                 4
                                                                                5
                             2
                                                                                           6
                                                                                                      7
                                          2
            Ramsdell K , Hanaway PJ 8
                       2
            1 The Center for Functional Medicine, Stamford CT
            2 The Institute for Functional Medicine, Federal Way, WA
            3 Boulder Wellcare, Boulder, CO
            4 Stone Medical, Ashland, OR
            5 Point Institute, Stevens Point, WI
            6 The Yanuck Center for Life and Health, Chapel Hill, NC
            7 Medical Intelligence Learning Lab, Inc (MILLI), San Jose, CA
            8 The Institute for Functional Medicine COVID-19 Task Force, Federal Way, WA
              Abstract
                 As the novel infection with SARS-CoV-2 emerges,   infectious  SARS-CoV-2  virus.  While  there  are  limited
              objective  assessment  of  the  scientific  plausibility  of   studies  to  validate  these  agents  to  specifically  prevent
              nutraceutical and botanical interventions for prevention   COVID-19, they have been chosen based upon their level
              and  treatment  is  important.  We  evaluate  twelve  such   of  evidence  for  effectiveness  and  safety  profiles,  in  the
              interventions with mechanisms of action that modulate   context of other viral infections. These agents are to be
              the immune system, impair viral replication, and/or have   used in a patient-specific manner in concert with lifestyle
              been demonstrated to reduce severity of illness. These are   interventions  known  to  strengthen  immune  response
              examples of interventions that, mechanistically, can help   (see related article in this issue of IMCJ).
              protect  patients  in  the  presence  of  the  prevalent  and



            Background and Introduction                        •  Optimizing modifiable lifestyle factors in order to
               Health  professionals  and  the  public  must  be  well   improve overall immune function (an introductory
            informed  about  the  SARS-CoV-2  virus,  the  disease  it   document on boosting immunity is available ). This
                                                                                                    i
            causes (COVID-19), and how it spreads. This information   should  reduce  progression  from  colonization  to
            is  readily  available  and  not  within  the  scope  of  this   illness.
            document. At this time, there are no specific vaccines or   •  Personalized  consideration  of  therapeutic  agents
            uniformly  successful  treatments  for  COVID-19.  In  this   that may:
            context of insufficient evidence, the scope of this document     ■ Favorably modulate cellular defense and
            will  be  to  assess  the  scientific  plausibility  of  promising   repair mechanisms.
            prevention approaches and therapeutic (nutraceutical and     ■ Favorably modulate viral-induced
            botanical)  interventions  and  then  to  offer  clinical   pathological cellular processes.
            recommendations.                                         ■ Promote viral eradication or inactivation.
               With  respect  to  interventions,  the  practice  of     ■ Mitigate collateral damage from other
            Functional  Medicine  emphasizes  the  primacy  of  safety,   therapeutic agents.
            validity, and effectiveness. In the novel context of COVID-    ■ Promote resolution of collateral damage and
            19, validity in the form of published evidence is lacking.   restoration of function.
            Therefore,  validity  relies  upon  inferences  from  the   •  Treatment of confirmed COVID-19 illness (as per
            mechanisms  of  action  of  individual  agents  and/or   conventional standards and practice):
            published  outcomes  data  supporting  their  mitigating     ■ May reduce the severity and duration of acute
            effects on illness from other viral strains. Likewise, data   symptoms and complications.
            for  the  effectiveness  of  interventions  targeting  the  viral     ■ May  support  recovery  and  reduce  long-term
            mechanisms  of  COVID-19  are  nascent  and  rapidly    morbidity and sequelae.
            emerging. In this context, the following recommendations
            represent  the  Functional  Medicine  approach  to  the   Additional references are being collated and will be made
            COVID-19 crisis:                                 available in the future.

              •  Adherence  to  all  health  recommendations  from   i.  https://www.ifm.org/news-insights/boosting-immunity-functional-medicine-
               official sources to decrease viral transmission.  tips-prevention-immunity-boosting-covid-19-coronavirus-outbreak/


       34   Integrative Medicine • Vol. 19, No. S1 • Epub Ahead of Print  Evans—Virus-Specific Nutraceutical and Botanical Agents
   31   32   33   34   35   36   37   38   39   40   41